Notice of convocation of the Extraordinary General Shareholders Meeting and documents related to the Extraordinary General Meeting

Current report No. 59/2023

Date of preparation: 7 December 2023

Subject: Notice of convocation of the Extraordinary General Shareholders Meeting and documents related to the Extraordinary General Meeting

Legal basis: Article 56 sec. 1 point 2 of the Public Offering Act – current and periodical information

The Management Board of Captor Therapeutics S.A., based in Wrocław (the "Company"), pursuant to Article 398, Article 399 § 1 in connection with Articles 402¹ and 402² of the Commercial Companies Code, informs that the Extraordinary General Shareholders Meeting of the Company was convened for 04 January 2024, at 14:00 and will be held in Wrocław at ul. Duńska 9 (54-427 Wrocław), in the DELTA Building.

The Management Board of the Company encloses the following documents to this report:

1. the full text of the notice with the agenda of the Extraordinary General Shareholders Meeting (appendix no. 1);

2. draft resolutions of the the Extraordinary General Meeting of the Company (appendix no. 2);